Designing Natural Dual Inhibitors for CDK-1 and PARP-1
In a groundbreaking study geared towards developing effective cancer therapies, researchers have undertaken a detailed exploration of dual inhibitors targeting cyclin-dependent kinase 1 (CDK-1) and...
















